Anne Hollerbach

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies.

Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 07, 2025

Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia.

Association of Specific Antiphospholipid Antibodies to Platelet Count and Thrombocytopenia.

Journal: Thrombosis and haemostasis

Published: January 08, 2025

Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.

Journal: Blood

Published: August 22, 2023

Rapid translocation of intracellular toll-like receptors depends on endosomal NADPH oxidase.

Rapid translocation of intracellular toll-like receptors depends on endosomal NADPH oxidase.

Journal: European journal of immunology

Published: November 16, 2022

Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.

Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 25, 2021

Lipid presentation by the protein C receptor links coagulation with autoimmunity.

Lipid presentation by the protein C receptor links coagulation with autoimmunity.

Journal: Science (New York, N.Y.)

Published: April 06, 2020

Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α.

Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α.

Journal: Journal of thrombosis and thrombolysis

Published: October 16, 2019

Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.

Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.

Journal: Blood

Published: May 09, 2019

Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors.

Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors.

Journal: Thrombosis and haemostasis

Published: April 25, 2019

Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

Journal: Blood advances

Published: February 06, 2018

Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.

Antiphospholipid antibody-induced cellular responses depend on epitope specificity : implications for treatment of antiphospholipid syndrome.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 07, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026